Insulet
PODD
#1053
Rank
S$24.75 B
Marketcap
$352.91
Share price
0.35%
Change (1 day)
40.08%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): S$0.41 Billion

According to Insulet's latest financial reports the company's current earnings are S$1.87 Billion. In 2023 the company made an earning of S$0.33 Billion, an increase over its 2022 earnings that were of S$57.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.41 B22.25%
2023 S$0.33 B481.9%
2022 S$57.85 M-45.24%
2021 S$0.10 B43.35%
2020 S$73.68 M18.51%
2019 S$62.18 M41.16%
2018 S$44.05 M-711.95%
2017 -S$7.2 Million-56.85%
2016 -S$16.69 Million-79.31%
2015 -S$80.65 Million63.85%
2014 -S$49.23 Million31.04%
2013 -S$37.57 Million-21.96%
2012 -S$48.14 Million
2010 -S$45.91 Million-42.38%
2009 -S$79.68 Million-33.56%
2008 -S$0.12 Billion65.93%
2007 -S$72.27 Million209.75%
2006 -S$23.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$9.85 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.19 Billion-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.02 B 149.07%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.69 B 5,905.55%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.09 B 2,112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
S$7.57 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$13.62 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA